EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Epirubicin-sensitive detection with a CoWO4/reduced graphene oxide modified screen-printed electrode

Somayeh Tajik, Razieh Moghimian, Hadi Beitollahi

ADMET and DMPK · 08.05.2025 · 13 (3) · 2733

DOI: 10.5599/admet.2733 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ADMET and DMPK, online erschienen am 08.05.2025. Verfasst von Somayeh Tajik und 2 weiteren Autor:innen. Beteiligte Einrichtung: Research Centre of Tropical and Infectious Diseases, Kerman University of Medical Sciences, Kerman, Iran. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kerman University of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and purpose: Because of its antimetabolic and cytotoxic qualities, epirubicin (EP), a crucial chemotherapeutic drug, has been used to treat a number of cancers, including those of the prostate, breast, ovary, stomach, lung, and colon. Experimental approach: In this study, CoWO4/reduced graphene oxide (CoWO4/rGO) nanocomposite was synthesized and characterized by field emission-scanning electron microscopy and energy-dispersive X-ray spectroscopy. To provide a novel sensing platform for EP determination, a screen-printed electrode (SPE) surface was modified using the as-fabricated CoWO4/rGO nanocom¬posite. Key results: Using voltammetric techniques, the electrochemical behavior of the CoWO4/rGO nanocomposite modified SPE (CoWO4/rGO/SPE) for the EP detection was examined. CoWO4/rGO significantly reduced the overpotential of EP redox reaction and increased the rate of electron transfer between the electrode and analyte as compared to bare SPE. EP was quantitatively analyzed using differential pulse voltammetry. Conclusions: It was discovered that the linearity range was 0.01 to 190.0 μM. The sensitivity and limit of detection were 0.1529 μA μM-1 and 0.007 μM, respectively. Additionally, the constructed CoWO4/rGO/SPE sensor's practical applicability was investigated in pharmaceutical samples with good recovery outcomes.

Schlagwörter

Stichwörter der Autor:innen

CoWO4/reduced graphene oxide nanocompositecancerchemically modified electrodedrug analysisurine sample

Autor:innen und Institutionen

  • Research Centre of Tropical and Infectious Diseases, Kerman University of Medical Sciences, Kerman, Iran.
  • Environment Department, Institute of Science and High Technology and Environmental Sciences, Graduate University of Advanced Technology, Kerman, Iran.

Förderung

  • Kerman University of Medical Sciences

Zitieren

APA

Tajik, S., Moghimian, R., & Beitollahi, H. (2025). Epirubicin-sensitive detection with a CoWO4/reduced graphene oxide modified screen-printed electrode. ADMET and DMPK, 13(3), 2733. https://doi.org/10.5599/admet.2733

Vancouver

Tajik S, Moghimian R, Beitollahi H. Epirubicin-sensitive detection with a CoWO4/reduced graphene oxide modified screen-printed electrode. ADMET and DMPK. 2025;13(3):2733. doi:10.5599/admet.2733

BibTeX
@article{Tajik2025,
  author = {Tajik, Somayeh and Moghimian, Razieh and Beitollahi, Hadi},
  title = {Epirubicin-sensitive detection with a CoWO4/reduced graphene oxide modified screen-printed electrode},
  journal = {ADMET and DMPK},
  year = {2025},
  volume = {13},
  number = {3},
  pages = {2733},
  doi = {10.5599/admet.2733}
}
Kostenlos starten →